Medical Company Medgenics Raises $29.4 In Public Offering

Israeli company Medgenics Ltd., has raised $29.4 million in a public offering on Wall Street. Medgenics is developing a unique sustained-action therapeutic protein delivery technology for the treatment of a range of chronic diseases. The technology – called a “Biopump” – is made from the patient’s own skin and is implanted in a simple procedure to work inside the patient’s body.